Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NORTHFIELD, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group...
-
Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Spain Existing & Upcoming Data Center Portfolio" report has been added to ResearchAndMarkets.com's offering. Spain hosts around 65 Data...
-
WALTHAM, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that Mikael Dolsten, M.D., Ph.D., has joined the company’s board of directors as of...
-
ST. GALLEN, Switzerland, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Super Technologies (Super), through their leading commercial brand Superbet, has deepened its long-standing relationship with Sportradar AG...
-
OAKLAND, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today announced the successful completion of its...
-
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Smartsheet Inc. (“Smartsheet” or the “Company”) (NYSE: SMAR). Such investors...
-
Ottawa, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The global data analytics market size was estimated at USD 64.75 billion in 2025 and is predicted to reach around USD 785.62 billion by 2035, growing at a...
-
CALGARY, Alberta, Feb. 22, 2026 (GLOBE NEWSWIRE) -- (“Canacol” or the “Company”) announces a leadership change and the appointment of an independent director to the board of directors (the “Board”)....
-
Ottawa, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The global central nervous system therapeutic market size was calculated at USD 127.29 billion in 2025 and is predicted to attain around USD 285.72 billion...
-
Appointment is a positive endorsement of NovaBridge’s unique hub-and-spoke model and focus on creating shareholder value by accelerating the development of transformative medicines for patients around...